jueves, 17 de septiembre de 2020

COVID-19 herd immunity: where are we? | Nature Reviews Immunology

COVID-19 herd immunity: where are we? | Nature Reviews Immunology



The cost of ‘natural’ herd immunity

“The cost of reaching herd immunity through natural infection would be very high,” write infectious-disease researchers Arnaud Fontanet and Simon Cauchemez. An effective vaccine is the safest way to subdue large coronavirus outbreaks through widespread immunity, they say in a sober overview of what’s at stake. They note that an “optimistic” herd immunity threshold of 50% would not be reached in the United States before “500,000–2,100,000 deaths”.
Nature Review Immunology | 7 min read

No hay comentarios:

Publicar un comentario